EquityBulls

Latest News

CFF Fluid Control Ltd receives LOI worth Rs. 27.74 crores
Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
Goodluck India Ltd enters into Strategic Alliance with BrahMos Aerospace Thiruvananthapuram Ltd and Axiscades Technologies Ltd to Bid for AMCA's Indigenous Manufacturing
IRIS Business Services Ltd receives contract in Qatar
Kirloskar Brothers Ltd receives order for pump sets from IOCL

Keywords Selected: MHRA

Stock Report

Relonchem Limited receives Marketing Authorization for its products
CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars
BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA
CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK's MHRA
Aarti Drugs Ltd's subsidiary receives CGMP certificate from UK MHRA
Relonchem Limited receives Marketing Authorization from UKMHRA for its products
UK Relonchem Ltd, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets
Relonchem Limited receives UKMHRA Marketing Authorization for its products
Relonchem Ltd receives Marketing Authorisation for the product Levetiracetam Relonchem 100 mg/mL Oral Solution
Sentynl Therapeutics receives marketing authorization for NULIBRY® from the UK MHRA for treatment of MoCD Type A
Biocon's European partner Zentiva receives approval from UK MHRA for Liraglutide
Biocon is the first generics Company to obtain approval for diabetes drug, Liraglutide, in the U.K.
Biocon Biologics Receives MHRA, UK Approval for YESAFILI®, Biosimilar Aflibercept
UK MHRA renews GMP compliance of Kopran Ltd's two plants
Shilpa Medicare receives UK‐MHRA Approval for Betahistine Dihydrochloride Orodispersible Films, 24 mg
Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
Lupin announces UK MHRA Approval of Lutio® for Treatment of COPD
Shilpa Medicare Limited, Unit VI, Bengaluru facility has been issued UK MHRA GMP
Brooks Steriscience Ltd recieves UK MHRA marketing authorization for Meropenem Injection
MHRA Inspection at Alkem's Bioequivalence Center at Taloja
Marksans Pharma announces UK MHRA approval for Bells Healthcare All in One Oral Solution